Evidence map›Paper›PMID 28877731›Full record

ArticleActa veterinaria Scandinavica2017

Hypoluteoidism in a dog associated with recurrent mammary fibroadenoma stimulated by progestin therapy.

Maria Teresa Zedda, Luisa Bogliolo, Elisabetta Antuofermo, Laura Falchi, Federica Ariu, Giovanni Pietro Burrai, Salvatore Pau

Open access · goldAbstract readCase Reports
In one paragraph

Article in Acta veterinaria Scandinavica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Maria Teresa ZeddaSection of Obstetrics and Gynecology, Department of Veterinary Medicine, University of Sassari, Via Vienna n.2, 07100, Sassari, Italy.
Luisa BoglioloSection of Obstetrics and Gynecology, Department of Veterinary Medicine, University of Sassari, Via Vienna n.2, 07100, Sassari, Italy.
Elisabetta AntuofermoSection of Pathology, Department of Veterinary Medicine, University of Sassari, via Vienna n.2, 07100, Sassari, Italy.
Laura FalchiSection of Obstetrics and Gynecology, Department of Veterinary Medicine, University of Sassari, Via Vienna n.2, 07100, Sassari, Italy. lfalchi@uniss.it.
Federica AriuSection of Obstetrics and Gynecology, Department of Veterinary Medicine, University of Sassari, Via Vienna n.2, 07100, Sassari, Italy.
Giovanni Pietro BurraiSection of Pathology, Department of Veterinary Medicine, University of Sassari, via Vienna n.2, 07100, Sassari, Italy.
Salvatore PauSection of Obstetrics and Gynecology, Department of Veterinary Medicine, University of Sassari, Via Vienna n.2, 07100, Sassari, Italy.
University of Sassari · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHypoluteoidism in the bitch is characterized by insufficient production and secretion of progesterone by the corpora lutea. It is a rare pathologic condition and during pregnancy, it leads to embryonic resorption or fetal abortion. Supplementary therapy with progestins is indicated during pregnancy to obtain delivery of vital puppies but unwarranted side effects of such treatment are poorly documented. CASE PRESENTATION: A 4-year-old, nulliparous, female Istrian Shorthaired Hound dog had been mated repeatedly in six heats with different dogs of proven fertility but signs of pregnancy did not develop. Estrous cycles, mating and pregnancies were monitored as hypoluteoidism or genital disease was suspected. During the first monitored estrus, the bitch was mated and on day 18 [day 0, day of estimated peak of luteinizing hormone (LH)], ultrasound examination showed three amniotic vesicles that were however found to be resorbed between day 20 and 23. Progesterone concentrations, measured by ELISA, were >8 ng/mL until day 12 and 1-2.5 ng/mL on days 20, 23 and 26. Primary hypoluteoidism was therefore suspected. In the second monitored estrus, the bitch was mated and during pregnancy, progesterone concentrations were >8 ng/mL until day 17 and 1-2.5 ng/mL on day 19. On days 20 and 22, two out of three embryonic vesicles had been resorbed. The bitch was treated with progesterone in oil from day 19 to day 58. Increase in the size of 2nd left thoracic mammary gland (T2-L) was observed and on day 46, ultrasound evaluation and biopsy were performed revealing a low-cellularity fibroadenoma. Parturition started spontaneously at day 65 but due to dystocia caused by fetal macrosomia, a Caesarean section was performed. During the next (third) monitored estrus, the bitch was bred again and during pregnancy, early decrease in progesterone concentration confirmed the diagnosis of primary hypoluteoidism. The bitch was treated with synthetic progestin (altrenogest) from day 8 to day 57. Five amniotic vesicles were detected by ultrasonography. Recurrence of swelling of T2-L was observed. On day 60, the bitch whelped five pups, two males and three females. As reported later by the owner, the latter did not show any sign of heat over the past 3 years. In one of them, clitoral hypertrophy and a blind ending vagina were diagnosed.

conclusionsThis is the first description of early hypoluteoidism in a pregnant bitch developing a mammary fibroadenoma under progestin treatment.

Indexed as

AnimalsDog DiseasesDogsFemaleFibroadenomaMammary Neoplasms, AnimalNeoplasm Recurrence, LocalPregnancyProgesteroneProgestinsTrenbolone AcetatealtrenogestProgesteroneProgestinsTrenbolone AcetateHypoluteoidismMammary fibroadenomaPregnant bitchProgestin treatment

Identifiers

PMID28877731
PMCPMC5585916
OpenAlexW2751132639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.